Add-On LAMA Therapy in Asthma: An Underused Strategy for Exacerbation Prevention

12 Feb 20264 min read0 viewsJournal Feed

GIST (Key Takeaways)

Asthma, an inflammatory disorder of the lower airways, affects 260 million people worldwide.1 The condition is characterised by variable airflow limitation, respiratory symptoms, and episodic exacerbations often resulting from pulmonary infections and/or aeroallergen exposures.
The mainstay of asthma treatment is inhaled corticosteroids combined with a long-acting β2-agonist (ICS–LABA).2 However, one in three patients have uncontrolled asthma or impaired lung function despite medium-dose ICS-LABA (Global Initiative for Asthma [GINA] Step 4).